Capricor Therapeutics

CAPR • NASDAQ

Capricor Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Linda Marbán, with a market cap of $1.7B.

Market Cap$1.7B

Employees102.0

CEOLinda Marbán

CountryUnited States of America

Healthcare

Biotechnology

Next EarningsMay 12, 2026 · in a monthQ1 2026

Financials

Common questions about Capricor Therapeutics

Capricor Therapeutics is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $25.2M.

Capricor Therapeutics has approximately 102 employees.